Anteris Technologies Global Corp. Common Stock (AVR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anteris Technologies Global Corp. Common Stock (AVR) has a cash flow conversion efficiency ratio of -0.083x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-20.80 Million) by net assets ($251.67 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AVR stock market capitalisation for the company's overall valuation and market capitalisation.
Anteris Technologies Global Corp. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Anteris Technologies Global Corp. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Anteris Technologies Global Corp. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anteris Technologies Global Corp. Common Stock ranked by their cash flow conversion efficiency. See AVR operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sheela Foam Limited
NSE:SFL
|
0.036x |
|
Anhui Zhonghuan Environmental Protection Technology Co Ltd
SHE:300692
|
0.021x |
|
Pakuwon Jati Tbk
JK:PWON
|
0.026x |
|
Tangrenshen Group Co Ltd
SHE:002567
|
0.038x |
|
Beijing Global Safety Technology Co Ltd
SHE:300523
|
-0.019x |
|
Shenzhen Fuanna Bedding and Furnishing Co Ltd
SHE:002327
|
0.030x |
|
Haining China Leather Market Co Ltd
SHE:002344
|
-0.023x |
|
Lian Hwa Foods Corp
TW:1231
|
0.086x |
Annual Cash Flow Conversion Efficiency for Anteris Technologies Global Corp. Common Stock (2020–2025)
The table below shows the annual cash flow conversion efficiency of Anteris Technologies Global Corp. Common Stock from 2020 to 2025. View AVR stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-253.00K | $-77.80 Million | 307.522x | +31575.77% |
| 2024-12-31 | $62.68 Million | $-61.24 Million | -0.977x | +46.69% |
| 2023-12-31 | $18.90 Million | $-34.63 Million | -1.833x | +43.73% |
| 2022-12-31 | $9.03 Million | $-29.42 Million | -3.257x | -137.39% |
| 2021-12-31 | $10.52 Million | $-14.44 Million | -1.372x | +77.03% |
| 2020-12-31 | $1.86 Million | $-11.08 Million | -5.971x | -- |
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT ant… Read more